Invention Grant
- Patent Title: Crystalline form E1 of larotrectinib ethanesulfonate
-
Application No.: US16754845Application Date: 2018-10-31
-
Publication No.: US11339164B2Publication Date: 2022-05-24
- Inventor: Sharona Shachan-Tov , Doron Rudik , Oshrat Frenkel , Rotem Sella-Erez , Maytal Piran , Ido Fuchs
- Applicant: ASSIA CHEMICAL INDUSTRIES LTD.
- Applicant Address: IL Petach Tikva
- Assignee: ASSIA CHEMICAL INDUSTRIES LTD.
- Current Assignee: ASSIA CHEMICAL INDUSTRIES LTD.
- Current Assignee Address: IL Petach Tikva
- Agency: Carter, DeLuca & Farrell LLP
- International Application: PCT/US2018/058316 WO 20181031
- International Announcement: WO2019/089668 WO 20190509
- Main IPC: A61K31/519
- IPC: A61K31/519 ; C07D487/04
Abstract:
Salts and solid state forms of Larotrectinib, processes for preparation thereof, pharmaceutical compositions thereof, and uses thereof are disclosed.
Public/Granted literature
- US20200255435A1 SALTS AND SOLID STATE FORMS OF LAROTRECTINIB Public/Granted day:2020-08-13
Information query
IPC分类:
